Grifols' shares rise 16% after auditor's 2023 results opinion [Reuters]
GRIFOLS SA S/ADR (GIKLY)
NASDAQ:AMEX Investor Relations:
grifols.com/en/web/international/investor-relations/home-page
Company Research
Source: Reuters
after it said auditor KPMG approved its 2023 results with an unqualified opinion, without modifying the profit and debt ratio previously reported. Grifols last week published its 2023 results , pending an audit, which analysts said contributed to the share price's tumbling along with doubts about its cash flow for 2024. Since early January, a report by short-seller fund Gotham City Research that questioned Grifols' accounting and debt ratio has cast doubts about the company's business and wiped off billions of euros in market value. On its audited results on Friday, Grifols said it now includes the integration of a junior venture with firm ImmunoTek, a deal to develop 28 plasma collection centres signed 2021. The deal with ImmunoTek was in the spotlight after Grifols said last week it would impact its free cash flow in 2024 by 415 million euros. Without it, Grifols said cash flow would increase by close to 500 million euros ($546.80 million) to approximately 900 euros million.
Show less
Read more
Impact Snapshot
Event Time:
GIKLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GIKLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GIKLY alerts
High impacting GRIFOLS SA S/ADR news events
Weekly update
A roundup of the hottest topics
GIKLY
News
- Grifols 2023 Annual Report on Form 20-F filed with the SEC [Yahoo! Finance]Yahoo! Finance
- Grifols reportedly looking to appoint independent directors [Seeking Alpha]Seeking Alpha
- Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper [Yahoo! Finance]Yahoo! Finance
- Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper [Reuters]Reuters
- Grifols Plans First Bond Sale Since Short Seller Attack [Yahoo! Finance]Yahoo! Finance